Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
0.589
-0.035 (-5.58%)
At close: Apr 28, 2026, 4:00 PM EDT
0.582
-0.008 (-1.29%)
Pre-market: Apr 29, 2026, 6:49 AM EDT
Galmed Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 4 | 4 | 5 | 2 | 13 | 46 | |
| Market Cap Growth | 84.62% | -14.46% | 163.69% | -85.53% | -72.40% | -31.12% | |
| Enterprise Value | -14 | -15 | -12 | -11 | -7 | 4 | |
| Last Close Price | 0.59 | 0.75 | 3.19 | 5.46 | 90.00 | 327.60 | |
| PB Ratio | 0.25 | 0.26 | 0.29 | 0.13 | 0.94 | 1.50 | |
| P/TBV Ratio | 0.25 | 0.26 | 0.29 | 0.13 | 0.94 | 1.50 | |
| Debt / Equity Ratio | - | - | - | 0.00 | 0.02 | 0.01 | |
| Net Debt / Equity Ratio | -1.15 | -1.15 | -0.94 | -0.91 | -1.01 | -1.13 | |
| Net Debt / EBITDA Ratio | 2.15 | 2.15 | 2.48 | 1.69 | 0.77 | 1.05 | |
| Net Debt / FCF Ratio | 2.88 | 2.88 | 2.61 | 2.05 | 0.73 | 1.05 | |
| Quick Ratio | 6.41 | 6.41 | 7.15 | 4.66 | 4.51 | 5.94 | |
| Current Ratio | 6.55 | 6.55 | 7.42 | 4.81 | 4.76 | 6.13 | |
| Return on Equity (ROE) | -64.21% | -64.21% | -49.77% | -50.63% | -81.36% | -86.98% | |
| Return on Assets (ROA) | -28.65% | -28.65% | -22.34% | -28.22% | -41.50% | -46.19% | |
| Return on Capital Employed (ROCE) | -53.90% | -53.90% | -38.50% | -54.00% | -131.10% | -107.00% | |
| Earnings Yield | -265.89% | -250.69% | -156.37% | -379.13% | -141.78% | -71.12% | |
| FCF Yield | -162.88% | -153.57% | -122.31% | -336.62% | -146.85% | -72.07% | |
| Buyback Yield / Dilution | -363.17% | -363.17% | -303.31% | -65.23% | -2.22% | -15.59% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.